2m 2m 2m 2m 2m 2m 2m
UNICYCIVE THERAP (UNCY)
NASDAQ
$4.25-$0.30 (-6.59%)
Price as of Oct 02, 2026 6:28 PM EDT- $126.7MMarket Cap
- -1.52%1-Year Change
- BiotechnologyIndustry
UNICYCIVE THERAP (UNCY)
$4.25-$0.30 (-6.59%)
UNCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.55 | ||
Change | -$0.14 (-3.09%) | ||
Open | $4.71 | ||
High | $4.76 | ||
Low | $4.54 | ||
Previous Close | $4.70 | ||
Volume | 1,068,823 | ||
30-Day Average Volume | 894,339 | ||
1-Week Change | -5.41% | ||
1-Month Change | -9.90% | ||
1-Year Change | -1.52% | ||
3-Year Change | -47.09% | ||
5-Year Change | -84.20% | ||
Fundamentals | |||
Shares Outstanding | 27.9M | ||
Total Assets | $72.0M | ||
Market Cap | $126.7M | ||
Enterprise Value | $82.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.8M | ||
Free Cash Flow | -$7.6M | ||
EBIT | -$1.8M | ||
EBITDA | -$1.7M | ||
Net Working Capital | $52.6M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -47 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -76 | ||
PEG | -1 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/20/2025 | ||
Earnings & Revenue